EpiVax licenses Tregitope Technology to Maruho Co., Ltd. for development of Tregitope-based Therapies to Treat Autoimmune Condition
PROVIDENCE, R.I., Nov. 4, 2021 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") is pleased to announce an important commercial licensing agreement with Maruho Co., Ltd. ("Maruho") for EpiVax's patented Tregitope technology. This marks an exciting step for Maruho and EpiVax towards continued expansion of the Tregitope program and translation to the clinic. Tregitopes...
International Federation of Robotics: “Service Robots” Hit Double Digit Growth Worldwide
FRANKFURT AM MAIN, Germany, Nov. 4, 2021 /PRNewswire/ -- The market for professional service robots reached a turnover of 6.7 billion U.S. dollars worldwide (sample method) – up 12% in 2020. At the same time, turnover of new consumer service robots grew 16% to 4.4 billion U.S. dollars. This is according to...
Gracell Biotechnologies to Present Preclinical Results of TruUCAR-enabled CD19/CD7 Dual-Directed Allogeneic CAR-T Cell Therapy (GC502) for B-Cell Malignancies at the 63rd ASH Annual Meeting
SUZHOU and SHANGHAI, China, and PALO ALTO, California, Nov. 4, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced preclinical data for GC502, an allogeneic chimeric antigen receptor (CAR) T...
I-Mab to Present Clinical Data of Lemzoparlimab in Combination with Rituximab in Non-Hodgkins’s Lymphoma at ASH 2021
Lemzoparlimab is a differentiated CD47 monoclonal antibody discovered by I-Mab and being developed in collaboration with AbbVie Initial clinical results of lemzoparlimab in combination with rituximab in NHL will be presented at the ASH 2021 Annual Meeting I-Mab to host a call for investors on December 14, 2021, at...
Volition Veterinary Presents Two Posters at the 2021 Veterinary Cancer Society Conference
Positive data show Nu.Q® can be used to monitor for disease response and progression including remission monitoring in cancer bearing dogs. Paves the way for second Nu.Q® Vet product launch planned for 2022. A second abstract details the first use of Nu.Q® Capture, Volition's enrichment tool, in the plasma of dogs with lymphoma. AUSTIN, Texas,...
Taizhou, China: Building a Famous Chinese Medical City with Efforts
TAIZHOU, China, Nov. 4, 2021 /PRNewswire/ -- Recently, the 12th China (Taizhou) International Medical Expo was held in China Medical City in Taizhou, China. Starting from the needs of normalized prevention and control of the epidemic, this year's expo made an "online+on-site" integrated exhibition, through the policy seminars, industry summits, cutting-edge technology promotion, innovative product display, talent exchanges, and...
Medigate Accelerates Expansion to Meet Growing Demand in Asia-Pacific Region
Healthcare's IoT cybersecurity and clinical asset management leader names APAC Regional Director. BROOKLYN, N.Y., Nov. 4, 2021 /PRNewswire/ -- Medigate, Healthcare's Security and Clinical Asset Management leader, today announced its expansion into the Asia-Pacific (APAC) region. Capitalizing on recently acquired landmark clients in Australia, Medigate's investment reflects its overall commitment to...
Transplant Connect and Cerner streamline organ donation and transplant process
Automated donor referrals help improve patient care and optimize hospital resources LOS ANGELES, Nov. 4, 2021 /PRNewswire/ -- Transplant Connect, a Los Angeles-based medical software company that has introduced innovative new technology known as iReferralSM, and Cerner Corporation, a global healthcare technology company, announce their new collaboration to enable automated donor referrals. This new technology is designed to help increase and expedite potential...
Tetracore, Inc. Introduces First USDA-Licensed Real-Time PCR Test for the Detection of African Swine Fever Virus in Swine Whole Blood and Spleen Samples
ROCKVILLE, Md., Nov. 4, 2021 /PRNewswire/ -- Tetracore, Inc. (Tetracore) announced today the licensing of their VetAlert™ African Swine Fever Virus (ASFV) DNA Diagnostic Test Kit by the United States Department of Agriculture (USDA) Center for Veterinary Biologics (CVB). It is the first USDA licensed diagnostic product for ASFV and is...
Alterity Therapeutics Announces New Publications Providing Further Evidence of the Potential of ATH434 to Treat Neurodegenerative Diseases
MELBOURNE, Australia, Nov. 4, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, today announced the publication of two preclinical studies demonstrating the potential of ATH434 to treat Parkinsonian disorders. Non-motor symptoms (NMS) are common...
